10 reports of this reaction
2.0% of all FLUDEOXYGLUCOSE F 18 reports
#11 most reported adverse reaction
WRONG PRODUCT ADMINISTERED is the #11 most commonly reported adverse reaction for FLUDEOXYGLUCOSE F 18, manufactured by Biomedical Research Foundation of Northwest Louisiana. There are 10 FDA adverse event reports linking FLUDEOXYGLUCOSE F 18 to WRONG PRODUCT ADMINISTERED. This represents approximately 2.0% of all 510 adverse event reports for this drug.
Patients taking FLUDEOXYGLUCOSE F 18 who experience wrong product administered should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
WRONG PRODUCT ADMINISTERED is a less commonly reported adverse event for FLUDEOXYGLUCOSE F 18, but still significant enough to appear in the safety profile.
In addition to wrong product administered, the following adverse reactions have been reported for FLUDEOXYGLUCOSE F 18:
The following drugs have also been linked to wrong product administered in FDA adverse event reports:
WRONG PRODUCT ADMINISTERED has been reported as an adverse event in 10 FDA reports for FLUDEOXYGLUCOSE F 18. This does not prove causation, but indicates an association observed in post-market surveillance data.
WRONG PRODUCT ADMINISTERED accounts for approximately 2.0% of all adverse event reports for FLUDEOXYGLUCOSE F 18, making it a notable side effect.
If you experience wrong product administered while taking FLUDEOXYGLUCOSE F 18, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.